Medindia

Merck Receives European Approval for ELONVA(R) (corifollitropin alfa injection), a New Fertility Treatment

WHITEHOUSE STATION, N.J., Jan. 28 /PRNewswire-FirstCall/ -- Merck & Co., Inc., which operates outside the U.S. and Canada as MSD, today announced the European ...
Medindia

Merck Receives CHMP Positive Opinion for New Fertility Treatment, ELONVA(R)

WHITEHOUSE STATION, N.J., Nov. 20 Merck & Co., Inc. today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has recommended approval of ...
Pharmabiz

Merck receives European nod for Elonva for fertility treatment

Elonva is the first sustained follicle stimulant. Due to its ability to initiate and sustain multiple follicular growth for an entire week, a single subcutaneous injection of the recommended dose of ...
Domain-b

Merck receives FDA approval for new fertility drug for women

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has recommended approval of US rug maker Merck & Co's new fertility treatment for women. The new drug, ...
The Korea Herald

Fertility treatment ‘Elonva’ approved

Elonva, infertility treatment by MSD-Korea, the Korean branch of the Merck & Co., gained the Korea Food and Drug Administration’s approval last week, the company said Monday. The follitropin beta ...